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Over the past years, the clinical relevance of covalent modification of druggable 
proteins by small molecules has been extensively debated within the medicinal 
chemistry community [1]. Covalent modification underlies the activity of successful 
drugs, as exemplified by aspirin, penicillin, and modern blockbusters like Pravacid, 
Nexium and Plavix. Nevertheless, there is still a rooted bias against covalent drugs, 
dismissed as “library polluters”, irrespective of the mechanism by which they 
ultimately bind to biomolecules. Because of concerns over non-specific toxicity and 
lack of selectivity, the Michael acceptor motif is rarely introduced in drug leads by 
design. Paradoxically, our diet is instead rife with Michael acceptors, and food plants 
provide countless leads to investigate the biological role of Michael reactivity in a 
molecular context substantially devoid of toxicity, at least at dietary dosages, and 
therefore of potential pharmaceutical relevance. To capitalize on this opportunity, we 
have developed an NMR assay (the cysteamine assay) that can identify the reactive 
sites in electrophilic natural products, rank them in terms of reactivity, and distinguish 
between transient and non-transient thiol trapping properties [2]. The application of 
the cysteamine assay to various classes of bioactive natural products will be presented, 
critically evaluating the information provided by the assay. 
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